← All indications
Pneumonia, Bacterial
Inflammation of the lung parenchyma that is caused by bacterial infections.
Subtype terms (7)
More specific conditions that are subtypes of Pneumonia, Bacterial in the MeSH hierarchy.
- Chlamydial Pneumonia
- Pneumonia, Mycoplasma
5 drugs approved
- Pneumonia of Calves, Enzootic
- Pneumonia of Swine, Mycoplasmal
- Pneumonia, Pneumococcal
25 drugs (14 approved, 11 experimental)
- Pneumonia, Rickettsial
- Pneumonia, Staphylococcal
19 drugs (11 approved, 8 experimental)
Drugs by status
Approved for this indication (17)
Phase 4 trials (4)
Phase 3 trials (23)
Phase 2 trials (12)
Phase 1 trials (5)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (29)
- Achaogen, Inc.
- The Medicines Company
- Merck
- Pfizer
- Bayer
- Cempra Inc
- Cubist
- Entasis Therapeutics
- Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
- Nektar Therapeutics
- R-Pharm
- Sponsor GmbH
- Fundación Pública Andaluza
- Albany College of Pharmacy and Health Sciences
- Albany Medical College
- Andaluz Health Service
- Duke University
- Summa Health System
- University of Seville
- Utrecht University
- Wayne State University
- Fudan University
- Taipei Medical University
- Jiao Tong University
- Melinta Therapeutics
- European Commission
- Department of Health and Human Services
- OCT Clinical Trials
- Johnson and Johnson
Organization Involved with Phase 2 Indications (12)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)